Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10561249rdf:typepubmed:Citationlld:pubmed
pubmed-article:10561249lifeskim:mentionsumls-concept:C0006142lld:lifeskim
pubmed-article:10561249lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:10561249lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:10561249lifeskim:mentionsumls-concept:C0006826lld:lifeskim
pubmed-article:10561249lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:10561249lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:10561249lifeskim:mentionsumls-concept:C0014582lld:lifeskim
pubmed-article:10561249lifeskim:mentionsumls-concept:C0039286lld:lifeskim
pubmed-article:10561249lifeskim:mentionsumls-concept:C0746319lld:lifeskim
pubmed-article:10561249lifeskim:mentionsumls-concept:C0232970lld:lifeskim
pubmed-article:10561249lifeskim:mentionsumls-concept:C0282116lld:lifeskim
pubmed-article:10561249lifeskim:mentionsumls-concept:C1512888lld:lifeskim
pubmed-article:10561249pubmed:issue7lld:pubmed
pubmed-article:10561249pubmed:dateCreated2000-6-7lld:pubmed
pubmed-article:10561249pubmed:abstractTextTo assess whether the addition of epirubicin (EPI) therapy to prolonged treatment with tamoxifen (TAM) improves relapse-free and overall survival in postmenopausal women with node-positive primary breast cancer.lld:pubmed
pubmed-article:10561249pubmed:languageenglld:pubmed
pubmed-article:10561249pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10561249pubmed:citationSubsetIMlld:pubmed
pubmed-article:10561249pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10561249pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10561249pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10561249pubmed:statusMEDLINElld:pubmed
pubmed-article:10561249pubmed:monthJullld:pubmed
pubmed-article:10561249pubmed:issn0732-183Xlld:pubmed
pubmed-article:10561249pubmed:authorpubmed-author:MartyMMlld:pubmed
pubmed-article:10561249pubmed:authorpubmed-author:WilsJ AJAlld:pubmed
pubmed-article:10561249pubmed:authorpubmed-author:CoombesR CRClld:pubmed
pubmed-article:10561249pubmed:authorpubmed-author:FontaineCClld:pubmed
pubmed-article:10561249pubmed:authorpubmed-author:Vassilopoulos...lld:pubmed
pubmed-article:10561249pubmed:authorpubmed-author:WoodsEElld:pubmed
pubmed-article:10561249pubmed:authorpubmed-author:MorvanFFlld:pubmed
pubmed-article:10561249pubmed:authorpubmed-author:BlissJ MJMlld:pubmed
pubmed-article:10561249pubmed:authorpubmed-author:OlmosTTlld:pubmed
pubmed-article:10561249pubmed:authorpubmed-author:Pérez-LópezF...lld:pubmed
pubmed-article:10561249pubmed:authorpubmed-author:CoombesGGlld:pubmed
pubmed-article:10561249pubmed:issnTypePrintlld:pubmed
pubmed-article:10561249pubmed:volume17lld:pubmed
pubmed-article:10561249pubmed:ownerNLMlld:pubmed
pubmed-article:10561249pubmed:authorsCompleteYlld:pubmed
pubmed-article:10561249pubmed:pagination1988-98lld:pubmed
pubmed-article:10561249pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10561249pubmed:meshHeadingpubmed-meshheading:10561249...lld:pubmed
pubmed-article:10561249pubmed:meshHeadingpubmed-meshheading:10561249...lld:pubmed
pubmed-article:10561249pubmed:meshHeadingpubmed-meshheading:10561249...lld:pubmed
pubmed-article:10561249pubmed:meshHeadingpubmed-meshheading:10561249...lld:pubmed
pubmed-article:10561249pubmed:meshHeadingpubmed-meshheading:10561249...lld:pubmed
pubmed-article:10561249pubmed:meshHeadingpubmed-meshheading:10561249...lld:pubmed
pubmed-article:10561249pubmed:meshHeadingpubmed-meshheading:10561249...lld:pubmed
pubmed-article:10561249pubmed:meshHeadingpubmed-meshheading:10561249...lld:pubmed
pubmed-article:10561249pubmed:meshHeadingpubmed-meshheading:10561249...lld:pubmed
pubmed-article:10561249pubmed:meshHeadingpubmed-meshheading:10561249...lld:pubmed
pubmed-article:10561249pubmed:meshHeadingpubmed-meshheading:10561249...lld:pubmed
pubmed-article:10561249pubmed:meshHeadingpubmed-meshheading:10561249...lld:pubmed
pubmed-article:10561249pubmed:meshHeadingpubmed-meshheading:10561249...lld:pubmed
pubmed-article:10561249pubmed:meshHeadingpubmed-meshheading:10561249...lld:pubmed
pubmed-article:10561249pubmed:meshHeadingpubmed-meshheading:10561249...lld:pubmed
pubmed-article:10561249pubmed:meshHeadingpubmed-meshheading:10561249...lld:pubmed
pubmed-article:10561249pubmed:meshHeadingpubmed-meshheading:10561249...lld:pubmed
pubmed-article:10561249pubmed:meshHeadingpubmed-meshheading:10561249...lld:pubmed
pubmed-article:10561249pubmed:meshHeadingpubmed-meshheading:10561249...lld:pubmed
pubmed-article:10561249pubmed:meshHeadingpubmed-meshheading:10561249...lld:pubmed
pubmed-article:10561249pubmed:year1999lld:pubmed
pubmed-article:10561249pubmed:articleTitleEpirubicin plus tamoxifen versus tamoxifen alone in node-positive postmenopausal patients with breast cancer: A randomized trial of the International Collaborative Cancer Group.lld:pubmed
pubmed-article:10561249pubmed:affiliationLaurentius Hospital, Roermond, The Netherlands.lld:pubmed
pubmed-article:10561249pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10561249pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:10561249pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:10561249pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:10561249pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:10561249pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10561249lld:pubmed